Global Markets for Emerging Medical Device Technologies

Report Highlights

The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025.

Report Includes

• 111 tables
• An overview of the global markets for emerging medical device technologies
• Analyses of global market trends, with data from 2019, 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2025
• Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
• Analyses of segments within the overall market including: aesthetics/dermatology, cardiovascular, dental, diabetes care, gastroenterology, nephrology, urology, gynecology/women's health, medical imaging/visualization, in-vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient management/monitoring
• An in depth look at growth driving factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years, technological advancements in medical devices, and the growing aging population
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
• Company profiles of the leading players operating in emerging medical device technologies market including 3M, Abbott Laboratories, Agilent Technology Inc., Boston Scientific, BioMérieux S.A., Cardinal Health, GE Healthcare, Medtronic, Novartis and Siemens Healthcare

Report Scope

Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle-based drug delivery, lab-based diagnostics, etc.) that have been in use over the last 30 years for the treatment and management of various diseases. Emerging medical device technologies include devices and technologies (e.g., bioresorbable implants, coated implants and balloons, transcatheter heart valves (TAVR, TMVR), electrophysiology, S-ICDs, cardioMEMS, wireless monitoring, wearable devices, needle-free drug delivery, capsule endoscopes, POC tests, companion diagnostics, etc. The format of the study is organized around the following topics: 

• Emerging medical device technologies used in general surgery, cardiovascular, diabetes care, gastroenterology, medical imaging/visualization, in vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient monitoring.
• Target disease demographics and cost burden.
• Regulatory structure.
• Unmet needs, market size and segmentation.
• Market drivers and restraints.
• Detailed market projections through 2024.
• Competition and market shares.
• Pricing and reimbursement.
• Marketed and pipeline (R&D) products along with descriptions, regulatory status and clinical trials.
• Observations and conclusions regarding the future of medical device technologies.
• Profiles of market participants and associations. 

Analyst Credentials

Vijay Laxmi has more than 20 years of experience in the health care domain. In addition to providing business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:

• Medical device markets.
• High-growth and niche markets in healthcare and life sciences.
• The home healthcare market.
• Medical tourism.